Globular adiponectin expression in mouse models of obesity or atherosclerosis can ameliorate their detrimental cardiometabolic phenotypes by improving insulin sensitivity and inhibiting the progression of atherosclerotic lesions [200]. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.